Experience
- NovartisGlobal Head Novartis Venture Fundcurrent2017 — presentBasel Area, Switzerland
- NovartisManaging Director Novartis Venture Fund2007 — 2017
- NovartisStrategic Assistant to Chairman and CEO2006 — 2007Basel Area, Switzerland
- SensirionIndependent Board Director (Verwaltungsrat)current2021 — presentGreater Zurich Area
- InnosuisseDirector Board of Directorscurrent2025 — presentSwitzerland
- Mediar TherapeuticsBoard Director2023 — 2025Boston, Massachusetts, United States
- SNSF Swiss National Science FoundationMember of the Board of Trustees (Stiftungsrat and Stiftungsratsausschuss)2021 — 2024Berne, Switzerland
- Forendo Pharma LtdBoard Director2014 — 2021Turku Area, Finland
- ArctosBoard Director2020 — 2021Basel, Switzerland
- Ribon TherapeuticsBoard Director2019 — 2021Greater Boston Area
- ETH ZürichInvestment Committee Member2019 — 2021Zurich, Switzerland
- University of ZurichBoard Director of UZH Life Sciences Fund2017 — 2020
- BRIDGE Programm (SNSF-Innosuisse)Steering Committee Member and POC Jury2018 — 2019Bern Area, Switzerland
- Bicycle TherapeuticsBoard Director2009 — 2019Cambridge, United Kingdom
- ANAVEON AGBoard Director2018 — 2019Basel, Switzerland
- BaseLaunchJury member2016 — 2018Basel Area, Switzerland
- Cutiss AGBoard director2017 — 2018Zürich Area, Switzerland
- F2GBoard director2011 — 2018Manchester, United Kingdom
- Sosei HeptaresBoard Director2009 — 2015London, Greater London, United Kingdom
- Covagen AGBoard Director2007 — 2014Zürich Area, Switzerland
- Nabriva Therapeutics plcBoard Director2008 — 2013Vienna, Vienna, Austria
- MerLion Pharmaceuticals Pte LtdBoard director2007 — 2009Singapore
- McKinsey & CompanyAssociate Partner2000 — 2006New York, New York
- United NationsInternship1997New York, New York
Skills & more
Board of DirectorsVenture Capital52Biotechnology23Life Sciences5Technology Transfer5Pharmaceutical Industry4Mergers & Acquisitions17M&A experience2Medical Devices7Strategy5Lifesciences5Start-ups5
+11 more
Corporate DevelopmentDue DiligenceCommercializationManagement ConsultingCross-functional Team LeadershipClinical DevelopmentStrategic PlanningDrug DevelopmentResearch and Development (R&D)Financial ModelingBiopharmaceuticalsFrom Anja's professional profile.
Deals · 1
Mediar TherapeuticsBoard seat
via Novartis Venture Fund · filed Oct 2024 · $85M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Novartis Venture Fund
Aaron Nelson
Managing Director at Novartis Venture Fund
Adam Cotton
Principal at Novartis Venture Fund
Anja König
Global Head at Novartis Venture Fund
Bart Dzikowski
Managing Director, Head of Transactions & Legal at Novartis Venture Fund
Beat Steffen
Managing Director at Novartis Venture Fund
Christoph Meier
Investor at Novartis Venture Fund
Elaine Jones
Investor at Novartis Venture Fund
Elena Battistello
Analyst at Novartis Venture Fund
Network5
Aaron Nelson
Managing Director at Novartis Venture Fund
Bart Dzikowski
Managing Director, Head of Transactions & Legal at Novartis Venture Fund
Beat Steffen
Managing Director at Novartis Venture Fund
Elena Battistello
Analyst at Novartis Venture Fund
Florian Muellershausen
Managing Director at Novartis Venture Fund
Investors connected to Anja in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Anja Koenig?
- Global Head of NVF at Novartis Venture Fund
- Where does Anja Koenig work?
- Anja Koenig is Global Head of NVF at Novartis Venture Fund.
- What boards does Anja Koenig sit on?
- Anja Koenig holds tracked board seats at Mediar Therapeutics.
- Where did Anja Koenig go to school?
- Anja Koenig studied at Cornell University (PhD, Physics); Ludwig-Maximilians-Universität München (Masters (Diplom), Physics); University of Oxford (Physics).
Same school
Also attended Cornell University748
Doug LeonePartner at Sequoia Capital; former Global Managing PartnerJenny LeeSenior Managing Partner at Granite AsiaNeeraj AgrawalGeneral Partner at Battery VenturesJohn ZimmerCo-founder of LyftMichelle FernandesInvestor at Index VenturesMicah RosenbloomGeneral Partner at Founder Collective
+ 742 more
Also attended Ludwig-Maximilians-Universität München143
Celine XiaoInvestor at DN CapitalFriedrich von WulffenPrincipal at Burda Principal InvestmentsElçinTalent Team at Hummingbird VenturesLaura WeigertSenior Associate at Marlin Equity PartnersToby TriebelPartner at FinTech CollectiveGabriel MatuschkaPartner at Fly Ventures
+ 137 more
Also attended University of Oxford990
Reid HoffmanCo-founder of LinkedIn; Partner at GreylockMichael MoritzFormer Partner at Sequoia Capital; Senior Adviser at Sequoia HeritageBrad GerstnerFounder & CEO of Altimeter CapitalGabriel PereyraCo-founder & President of HarveyDominic JacquessonInvestor at Index VenturesErin Price-WrightInvestor at Index Ventures
+ 984 more
Shared employers
Also worked at Innosuisse13
Martin ScherrerPartner & Head of Managed Funds at RedstoneReinhard VoelkelInvestor at Sand Hill AngelsMichael StuckyPartner at Serpentine VenturesAnja KönigGlobal Head at Novartis Venture FundMichael WackerManaging Partner at BioMedPartnersAndreas JurgeitPartner at Gimv
+ 7 more
Also worked at Ribon Therapeutics6
Marian NakadaVice President, Venture Investments at JJDCAnja KönigGlobal Head at Novartis Venture FundJeff GoaterPartner at The Column GroupChristian SchubertHead of AbbVie Ventures at AbbVieJodie MorrisonVenture Partner at Atlas VentureMarian NakadaVice President at Johnson & Johnson Innovation – JJDC











































%20(4).avif)







